NZ197856A - 9-amino-1-hydroxyoctahydrobenzo(c)-quinolines and derivatives - Google Patents

9-amino-1-hydroxyoctahydrobenzo(c)-quinolines and derivatives

Info

Publication number
NZ197856A
NZ197856A NZ197856A NZ19785681A NZ197856A NZ 197856 A NZ197856 A NZ 197856A NZ 197856 A NZ197856 A NZ 197856A NZ 19785681 A NZ19785681 A NZ 19785681A NZ 197856 A NZ197856 A NZ 197856A
Authority
NZ
New Zealand
Prior art keywords
hydrogen
carbon atoms
compound according
group
methyl
Prior art date
Application number
NZ197856A
Other languages
English (en)
Inventor
M R Johnson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NZ197856A publication Critical patent/NZ197856A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NZ197856A 1980-07-28 1981-07-27 9-amino-1-hydroxyoctahydrobenzo(c)-quinolines and derivatives NZ197856A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/173,207 US4309545A (en) 1980-07-28 1980-07-28 Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof

Publications (1)

Publication Number Publication Date
NZ197856A true NZ197856A (en) 1984-10-19

Family

ID=22630983

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ197856A NZ197856A (en) 1980-07-28 1981-07-27 9-amino-1-hydroxyoctahydrobenzo(c)-quinolines and derivatives

Country Status (29)

Country Link
US (1) US4309545A (en:Method)
EP (1) EP0045171B1 (en:Method)
JP (1) JPS57112372A (en:Method)
KR (1) KR850000273B1 (en:Method)
AR (1) AR230988A1 (en:Method)
AT (1) ATE11775T1 (en:Method)
AU (1) AU525944B2 (en:Method)
CA (1) CA1178274A (en:Method)
CS (1) CS228515B2 (en:Method)
DD (1) DD202012A5 (en:Method)
DE (1) DE3168891D1 (en:Method)
DK (1) DK334581A (en:Method)
EG (1) EG15535A (en:Method)
ES (1) ES8301926A1 (en:Method)
FI (1) FI812338A7 (en:Method)
GR (1) GR75283B (en:Method)
GT (1) GT198170557A (en:Method)
HU (1) HU185133B (en:Method)
IE (1) IE51426B1 (en:Method)
IL (1) IL63423A0 (en:Method)
IN (1) IN158867B (en:Method)
NO (2) NO812557L (en:Method)
NZ (1) NZ197856A (en:Method)
PH (1) PH17281A (en:Method)
PL (1) PL133928B1 (en:Method)
PT (1) PT73440B (en:Method)
SU (1) SU1217254A3 (en:Method)
YU (1) YU185181A (en:Method)
ZA (1) ZA815128B (en:Method)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920221A (en) * 1982-03-16 1990-04-24 Pfizer Inc. Substituted decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines
US4473704A (en) * 1982-03-16 1984-09-25 Pfizer Inc. Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta[1]phenanthrenes, decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US4642373A (en) * 1982-03-16 1987-02-10 Pfizer Inc. Substituted dodecahydrotripheylenes, and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US5605906A (en) * 1995-03-24 1997-02-25 Merck Frosst Canada, Inc. Cannabinoid receptor agonists
EE03523B1 (et) * 1996-01-31 2001-10-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine
ATE224386T1 (de) * 1996-03-26 2002-10-15 Altana Pharma Ag Neue in 6-position substituierte phenanthridine
US6127378A (en) * 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
US5776482A (en) * 1996-03-29 1998-07-07 University Of Iowa Research Foundation Tetrahydroquinoline analogues for use in glaucoma treatment
PT1000035E (pt) * 1997-07-25 2003-04-30 Altana Pharma Ag 6-fenilfenantridinas substituidas
ATE224372T1 (de) * 1997-07-25 2002-10-15 Altana Pharma Ag Substituierte 6-alkylphenanthridine
BR0009200A (pt) 1999-03-22 2001-12-26 Immugen Pharmaceuticals Inc Compostos e composições para o tratamento dedoenças associada com disfunção imune
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US20060084021A1 (en) * 2004-09-10 2006-04-20 Kubicek Chris A Wick holder
AU2001296402A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
AU2002213429A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
AU2003214226A1 (en) * 2002-03-18 2003-10-08 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
NZ551379A (en) * 2004-05-25 2010-11-26 Othera Holding Inc Oculoselective drugs and prodrugs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839441A (en) * 1969-10-27 1974-10-01 Hoffmann La Roche Intermediates for partially hydrogenated phenanthridines
US3878219A (en) * 1973-07-13 1975-04-15 Abbott Lab 5H-{8 1{9 benzopyrano{8 3,4-d{9 pyridines
US3928598A (en) * 1973-11-05 1975-12-23 Lilly Co Eli Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
HU180916B (hu) 1976-05-17 1983-05-30 Pfizer Eljárás benzo[c]kinolin-származékok előállítására
US4152450A (en) * 1978-02-17 1979-05-01 Eli Lilly And Company 9-Amino-dibenzopyrans

Also Published As

Publication number Publication date
AU525944B2 (en) 1982-12-09
PL232331A1 (en) 1983-09-26
US4309545A (en) 1982-01-05
FI812338L (fi) 1982-01-29
ES504323A0 (es) 1982-12-16
GT198170557A (es) 1983-01-12
HU185133B (en) 1984-12-28
IL63423A0 (en) 1981-10-30
EP0045171A2 (en) 1982-02-03
PL133928B1 (en) 1985-07-31
ZA815128B (en) 1982-07-28
AR230988A1 (es) 1984-08-31
PT73440A (en) 1981-08-01
PT73440B (en) 1983-06-20
IE51426B1 (en) 1986-12-24
KR850000273B1 (ko) 1985-03-15
DE3168891D1 (en) 1985-03-28
GR75283B (en:Method) 1984-07-13
EG15535A (en) 1986-09-30
JPS57112372A (en) 1982-07-13
ATE11775T1 (de) 1985-02-15
NO854454L (no) 1985-01-29
YU185181A (en) 1983-12-31
CS228515B2 (en) 1984-05-14
DK334581A (da) 1982-01-29
ES8301926A1 (es) 1982-12-16
SU1217254A3 (ru) 1986-03-07
DD202012A5 (de) 1983-08-24
EP0045171B1 (en) 1985-02-13
CA1178274A (en) 1984-11-20
FI812338A7 (fi) 1982-01-29
IN158867B (en:Method) 1987-02-07
AU7343481A (en) 1982-05-06
PH17281A (en) 1984-07-06
NO812557L (no) 1982-01-29
EP0045171A3 (en) 1982-04-28
KR830006217A (ko) 1983-09-20
IE811686L (en) 1982-01-28

Similar Documents

Publication Publication Date Title
NZ197856A (en) 9-amino-1-hydroxyoctahydrobenzo(c)-quinolines and derivatives
GEP20002210B (en) Acridine Derivatives
ATE20469T1 (de) Carboxyalkyl-dipeptide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
RU97112857A (ru) Новые иммунотерапевтические ариламиды
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
DE3689311D1 (de) Tricyclische Verbindungen.
KR950000693A (ko) 프로펜산 유도체
KR940005597A (ko) 4, 1- 벤즈옥사제핀 유도체 및 그의 용도
GB9310582D0 (en) Pharmaceuticals
HU9201578D0 (en) A new peptide and method for producing it
BG103426A (en) Derivatives of substituted 4-biphenyl-4-hydroxy-oil acids as inhibitors of matrix metalloproteases
CA2149872A1 (en) Diabetes prevention and treatment
ATE81655T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung.
DE3576075D1 (de) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
GB1268951A (en) Phenoxy-amines
ES468170A1 (es) Un procedimiento para la preparacion de un nuevo derivado demorfina
ES8401926A1 (es) Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias.
ATE146476T1 (de) Cephalosporinverbindungen und verfahren zu ihrer herstellung
KR920005986A (ko) 혈소판 응집 억제용 약제학적 조성물
MD776B2 (en) Inclusion complexes of 3-morpholinesydnonimine or its salts,or its tautomeric isomer with cyclodextrine or its derivatives, method for preparation thereof, pharmaceutical composition thereof, method for preparation thereof and for treatment of stenocardia or ishemic desease
GB1360860A (en) Cepham compounds process for their manufacture and compositions containing them
GB1465769A (en) Carbamates of ergolines
KR850006003A (ko) 안트라퀴논 유도체의 제조방법
KR900006309A (ko) 신규 2-카르보닐 치환 n, n'-디-(트리메톡시벤조일)피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물
GB1468079A (en) Ethanolamine derivatives